SERIES B·Nov 10, 2026, 9:11 PM ET·Emerging signal

Zus Health raises $33M and seeks healthcare data-exchange network designation

TL;DR:

  • Drive Capital led Zus Health's $33 million Series B, with new and existing investors participating.
  • Zus Health also announced candidacy for a healthcare data-exchange network designation.
  • The candidacy isn't an approval.

Summary

Zus Health raised $33 million in Series B financing led by Drive Capital, with new and existing investors participating. Alongside the financing, it announced candidacy for QHIN designation under TEFCA. That distinction matters: the company is pursuing a healthcare data-exchange role, not reporting that it has already secured approval.

Open markets.businessinsider.com in a new tab ↗
Powered by Moatly Lens

The Bigger Picture

The headline tells you what happened. Discover the facts behind it, the forces at work, the connections that matter, and what comes next.

Why This Matters

New funding for Ocient and Zus Health shows investors are betting on startups that handle massive, regulated datasets.

What We Actually Know

  • Zus Health is pursuing a formal role in the national healthcare data-exchange network, though it hasn't been approved yet.
  • Reported, not yet confirmedOcient's total funding now stands at $260 million following its latest round co-led by BOKA Capital and OCA Ventures.

How the Pieces Connect

  • InferenceReported, not yet confirmedWhile Ocient focuses on the sheer volume of data, Zus is navigating the complex regulatory framework of U.S. health data sharing.

What This Could Change

  • ScenarioSecuring QHIN status would give Zus Health a significant competitive moat by making them a central hub for medical records.

Where the Story Goes Next

  • The timeline for Zus Health's final QHIN approval remains uncertain as the candidacy process is ongoing.